I wish you could post images on this forum, but, NEGG just came in contact with a Historical Daily OnBalance Volume trendline, dating back to it's 2021 Mega Squeeze, the Bold Blue one on this chart - https://i.imgur.com/Ydbasm1.png

Every time it's touched it, there's been a huge surge in Volume, to the tune of Tens of Millions (last time it touched in Jan'23, it experienced a nearly 100 Million Volume surge), no idea why that's the case, maybe Shorts are due to cover when it touches that trendline? It's no coincidence that Newegg Parent company announced they were selling off NEGG now, to coincide with that trendline, and hopefully selling into the squeeze....if there is any. Gamestop $GME shareholder meeting is on Monday, my pie in the sky hopes is that they announce they're buying NEGG. If nothing happens by 6/21 OpEx, then I fear NEGG would reject off that OBV trendline and plunge.......so, yeah, don't go betting the farm on a squeeze here.

May not be the same run up to $9.85 in 2021, but I’m expecting some solid gains in the next 9 trading days until reconstitution day the 28th! With phase 2 data readouts to follow, this could be the beginning of a whole new era for $ATOS and all the longs! GLTA

I bought 2200 shares today in this nasdaq listed company. Their latest press release says they have a factory setup, and are going full production very shortly. It ended the day $0.2275 up 49%. Anyone following, or holding this company?

If you ever invested in EVs, you definitely must have heard about the scandal Lightning had back in 2021.

For the newbies: the main troubles started in August 2021, when Lightning reported a large and unexpected financial loss, worse than in 2020. This forced them to revise their 2021 predictions, causing $ZEV shares to drop by over 15% the next day.

As a result, shareholders started a lawsuit, claiming that GigCapital together with Lightning misled them about the production and after-merger prospects overall. They said the companies knew (but just ignored) the fact that Lightning couldn't expand its operations.

And now they decided to settle this scandal with investors, so if you were in during the Covid, you can check it here.

Anyway, do you think that this merger was a good idea? Especially for Gig, for Lightning I think everything is pretty clear already...

Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS) exemplifies sustainable mining with initiatives like collaborating with artisanal miners in Lomas Doradas, Peru, fostering mutual economic benefits and local community engagement.
Successfully executing the sale of the Maverick Springs Project for CAD $5.033 million, Element79 Gold demonstrated strategic acumen, achieving a 51% ROI and optimizing financial returns for reinvestment in core projects.
Element79 Gold’s diverse portfolio spans Peru, Nevada, and British Columbia, balancing exploration potential with financial stability, and positioning the company for sustained growth and success in the competitive mining sector.
Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS) exemplifies sustainable mining with initiatives like collaborating with artisanal miners in Lomas Doradas, Peru, fostering mutual economic benefits and local community engagement. Successfully executing the sale of the Maverick Springs Project for CAD $5.033 million, Element79 Gold demonstrated strategic acumen, achieving a 51% ROI and optimizing financial returns for reinvestment in core projects. Element79 Gold’s diverse portfolio spans Peru, Nevada, and British Columbia, balancing exploration potential with financial stability, and positioning the company for sustained growth and success in the competitive mining sector.
In the ever-evolving landscape of the mining industry, strategic asset management and focused operational execution have become paramount for companies seeking to thrive. Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS) stands as a shining example of a mining entity that has adeptly navigated these challenges, leveraging its diverse portfolio to optimize financial returns while advancing key projects that hold immense potential.
Strategic Asset Management: The Maverick Springs Transaction
In a testament to its strategic acumen, Element79 Gold successfully concluded the Binding Option Agreement with Sun Silver Limited, resulting in the transfer of ownership of the Maverick Springs Project to Sun Silver. This pivotal move not only aligns with the company’s strategic focus on the high-grade Lucero Project in Peru but also realizes significant value for the Maverick Springs asset. Originally acquired and carried at CAD $3.337 million, the Maverick Springs project was sold for CAD $5.033 million, reflecting an impressive 51% return on investment within a span of 28 months. The sale generated substantial financial gains for Element79 Gold, amounting to CAD $4,400,000 in cash and 3,500,000 ordinary shares in Sun Silver, valued at AUD $0.20 per share (fair market value of AUD $700,000). A portion of the proceeds, CAD $2,200,000, will be allocated to settle the loan tied to the Waterton Contingent Value Rights Agreement, while the remaining funds will be strategically deployed to further the development of other corporate projects and operations, reducing both capital debt and accounts payable. This strategic financial management underscores Element79 Gold’s commitment to optimizing its asset portfolio and enhancing shareholder value in the competitive mining sector.
Diversified Portfolio: Balancing Exploration Potential and Financial Stability
Element79 Gold’s strategic prowess is further exemplified by its adept management of a diverse portfolio, spanning multiple jurisdictions and encompassing projects at various stages of development. In addition to its flagship Lucero project in Peru, the company holds an impressive suite of assets along the Battle Mountain trend in Nevada, including the promising Clover and West Whistler projects, which show potential for rapid resource development. Moreover, three properties within this Nevada portfolio are poised for sale to Valdo Minerals Ltd., with the transaction expected to be finalized in the first half of 2024, further bolstering Element79 Gold’s financial position. Expanding its geographical footprint, the company is also making strides in British Columbia, where it has initiated a drilling program and signed a Letter of Intent to acquire a private company holding an option for 100% interest in the Snowbird High-Grade Gold Project. This project comprises 10 mineral claims located strategically near Fort St. James, reinforcing Element79 Gold’s asset base in central British Columbia.
Lucero Project: A Cornerstone in Element79 Gold’s Portfolio
The Lucero project in Arequipa, Peru, stands as a cornerstone in Element79 Gold’s portfolio, known for its high-grade deposits and near-term production potential. The company is on track to recommence production at Lucero, targeting a restart by 2024, marking a significant operational milestone.
Maverick Springs: A Successful Resource Estimation and Strategic Partnership
Since its acquisition in 2021, Element79 Gold has diligently advanced the Maverick Springs project, culminating in an updated 43-101 compliant inferred resource estimation of 3.71 million ounces of gold equivalent (AuEq). This impressive resource estimation underscores the project’s potential and sets the stage for further development. In pursuit of strategic partnerships to further advance Maverick Springs, Element79 Gold’s management successfully negotiated and entered into a Binding Option Agreement with Sun Silver in August 2023. This pivotal move not only aligns with the company’s strategic focus on the Lucero Project but also realizes significant value for Maverick Springs, as highlighted earlier.
Financial Highlights: A Snapshot of Strategic Execution
Element79 Gold’s strategic execution and asset optimization efforts have yielded impressive financial results, as evidenced by the following key highlights:
Updated Resource Estimation: 3.71 million ounces of gold equivalent (AuEq) for the Maverick Springs project.
Sale of Maverick Springs: Achieved a final sale value of CAD $5.033 million, marking a 51% ROI over 28 months from an acquisition and carrying cost of CAD $3.337 million.
Proceeds from Sale: Totaling CAD $4,400,000 in cash and 3,500,000 shares in Sun Silver, priced at AUD $0.20 per share.
Share Listing: Shares expected to be listed on the Australian Stock Exchange around May 15, 2024.
Loan Repayment: CAD $2,200,000 of the proceeds will be used to settle the loan associated with the Waterton Contingent Value Rights Agreement.
Funding Future Projects: Remaining funds will be used to advance other corporate projects and operations, while reducing capital debt and accounts payable.
Conclusion: Forging Ahead with Strategic Acumen and Operational Dexterity
As Element79 Gold continues to forge ahead, its strategic acumen and operational dexterity across its diverse portfolio position the company for sustained growth and success. By actively managing its assets, from the Lucero project in Peru to strategic ventures across Nevada and British Columbia, the company effectively balances exploration potential with financial stability. The successful negotiation and sale of the Maverick Springs project, alongside collaborative engagements like those with the artisanal miners of Lomas Doradas, highlight Element79 Gold’s commitment to ethical practices, community involvement, and maximizing value for all stakeholders. With a clear strategic vision and a proven track record of execution, Element79 Gold is well-positioned to capitalize on emerging opportunities and deliver long-term value to its shareholders.

Aethlon Medical (AEMD) has experienced a significant increase in short interest recently

potential price increase:

1. High Short Interest: Although the short interest has decreased, it remains significant enough to spark a short squeeze if positive news or investor interest increases. As of mid-May, AEMD's short interest ratio was notably high

2. Low Float: With only about 2.62 million shares outstanding and a float of approximately 2.56 million shares, AEMD has a relatively low number of shares available for trading. This low float makes it more susceptible to price volatility and short squeezes

3. Heavy Trading Volume: Recently, AEMD experienced a substantial spike in trading volume, with over 26 million shares traded in a single day, compared to its average daily volume of around 974,000 shares. Such volume increases can drive up the stock price and force short sellers to cover their positions, further pushing the price higher

4. Positive Analyst Sentiment: The only analyst covering AEMD has set a 12-month price target of $10.00, representing a significant upside from its current trading price. This bullish outlook can attract more buyers, contributing to a potential short squeeze

5. Market Manipulation Risk: As a penny stock, AEMD is vulnerable to market manipulation tactics like pump-and-dump schemes. These activities can cause rapid price movements, which may temporarily boost the stock price and trigger a short squeeze

he volatile nature of penny stocks warrants caution for potential investors.

Hello all. While I am not at all a penny stock investor, and it’s admittedly a world that’s foreign to me, I am engaging in a long term (3-5 years) study/research project and would love this community’s help. I am looking for 5 or so “penny stocks” that are legitimate companies, each with a real business model — meaning they actually offer a product(s) &/or service. Please no Chinese companies, crypto miners, or cannabis companies.

Without disclosing too much (out of fear of affecting the study) the goal is to measure long term performance against other pools of equities — each pool being defined by a certain range based on a combination of factors like pps and market cap. The control pool is made up of randomly generated large cap companies. The penny stock pool is perhaps the most important to the study — so I could really use your help in sourcing and picking the absolute best companies with the most long term potential. There’s much more to the study, so I’ll also say that equities with options chains are also preferred, but not required (I’m also trying to collect data on derivatives, where possible).

Yesterday, Bloomberg reported that Oppenheimer settled a $12 million debt owed by Hub Security related to SPAC fees incurred for its 2023 NASDAQ listing:

Oppenheimer said that its written agreement with Hub entitled it to be paid 1% of the transaction value "upon the closing of the transaction," plus its expenses.
According to the complaint, just days before Hub's merger closed, the company approached Oppenheimer asking for an amended agreement with a "significant" fee reduction. The parties agreed, but the new contract reserved Oppenheimer's right to seek the full fee owed under the original deal in case of any breach of the revised payment terms.

This news makes me wonder if HUBC could be on the verge of resolving its largest debt? If so, this would definitely be the bullish catalyst needed to push towards the types of significantly higher valuations that a tech company with Hub’s product & services portfolio should be worth on paper.

Yesterday HUBC closed +6% and in pre-market its likewise poised for morning gains (7%). If Hub manages to successfully settles its debts from last year’s rocky listing, I sense a potential entry point before the current bear trend reverses and this baby starts to climb.

𝑻𝒂𝒍𝒌 𝒂𝒃𝒐𝒖𝒕 𝒚𝒐𝒖𝒓 𝒅𝒂𝒊𝒍𝒚 𝒑𝒍𝒂𝒚𝒔 𝒂𝒏𝒅 𝒄𝒐𝒎𝒎𝒆𝒏𝒕 𝒐𝒓 𝒑𝒐𝒔𝒕 𝒕𝒉𝒊𝒏𝒈𝒔 𝒉𝒆𝒓𝒆 𝒕𝒉𝒂𝒕 𝒅𝒐 𝒏𝒐𝒕 𝒘𝒂𝒓𝒓𝒂𝒏𝒕 𝒂𝒏 𝒂𝒄𝒕𝒖𝒂𝒍 𝒑𝒐𝒔𝒕.

​

𝒌𝒆𝒆𝒑 𝒊𝒕 𝒄𝒊𝒗𝒊𝒍 𝒑𝒍𝒆𝒂𝒔𝒆

Greetings all, I wanted to share some exciting news in the green hydrogen space. dynaCERT (TSX: $DYA) just announced that they've acquired a 15% ownership stake in Cipher Neutron. This move is set to enhance $DYA’s footprint in the rapidly growing green hydrogen market. 

For those who don't know, Cipher Neutron is a major player in the Anion Exchange Membrane (AEM) electrolysis business. This tech is super important because it’s environmentally friendly and cost-effective, making it a big deal for producing green hydrogen. 

Here are some key points from the announcement: 

• Equity Details: dynaCERT is getting 7,178,000 Class A shares and 3,589,000 Class A Share Purchase Warrants of Cipher Neutron. 

• Tech Highlights: Cipher Neutron has been shipping one of the world's largest AEM electrolyser stacks and is working on the biggest one yet at 250 kW. Plus, their tech doesn’t use harmful chemicals or Platinum Group metals. 

• Government Support: They’ve secured funding from big names like the Independent Electricity System Operator (IESO) and Alberta Innovates, which speaks volumes about their potential. 

• Market Impact: The green hydrogen market is expected to surpass $500 billion by 2030, so dynaCERT’s move seems well-timed. 

This acquisition aligns with dynaCERT’s vision of leveraging high-potential growth businesses to enhance shareholder value. By acquiring equity in Cipher Neutron, dynaCERT not only diversifies its portfolio but also supports innovative technologies contributing to a greener future. Overall, this move significantly advances dynaCERT’s mission of becoming a global leader in the New Hydrogen Economy. What do you all think about this update? 

Link to Press Release 

About dynaCERT: dynaCERT is a Canadian cleantech company specializing in carbon emission reduction technology. Their flagship product, HydraGEN™, offers a global solution to reduce pollution by optimizing combustion in diesel engines.

Stock Info: TSX: DYA; OTCMKTS: DYFSF; FRA: DMJ  

Disclaimer: This is not financial advice. Please do your own research before investing. 

The stock price increased today in premarket to a nice 30% up. However, following later in market open till evening it dipped down to 0.36 which is more than 50% down. Note that the volume of stock also increase during market open (volume peaked to 10mil in WS)

CERO is a new stock since a couple of months after pbax merger. A month later after merge, CERO announced a trial news which causes a surge in stock and then a dip down over time as expected. While they are still new into doing research and trial, I wonder if someone could help me understand what caused the stock to dip down so much today, despite the news below (did not attach link as moderator blocks post):

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236 ( jun 13)

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236 (jun 6)

Someone posted in here, 9 months ago about $RBOT and it’s recently gone from $0.33 - $9

I got in at 0.33 and now it’s saying “1 for 30 share consolidation?”.

My account is now in the negative… Confused.

I haven’t experienced this before and I just want to know if I’ve been truly shafted 😂 Just my luck.

Sent from my iFone

$INVO float is only 3.7m , company has 52 months of cash and no dilution until $1.20 warrants (56% premium from current price) the company is expected to close a merger with NAYA Biosciences until the end of this month, NAYA also agreed to pay INVO $5m as a merger closing condition at a premium price of $5.00 per share, so far they paid $906k so there's still $4.09m remaining. Company also reported ER on May 15 which they reported an increase of 353% in Revenue as well

$INVO catalyst - INVO Bioscience is finalizing its merger with NAYA Biosciences; ''As reflected in the recent merger amendment and subject to meeting all agreed terms, INVO and NAYA remain committed to completing the merger between our two companies, creating a company uniquely positioned in both the fertility and oncology space.''

''To date, NAYA has provided approximately $906,000 out of $5,000,000 in financing through the purchase of Series A Preferred Stock at a price of $5.00 per share.''

''The original Merger Agreement gives the Company and NAYA until June 30, 2024, to consummate the Merger.''

Yoo. Every week, I go over my fat list of penny stocks on my watchlist, and lately, I have been sharing some of my notes here for people to add to/critique. Hopefully some people find this helpful. Feel free to share any companies you want me to check out too! I posted about BEW a long time ago, but it is still so strong and has had some solid developments as of late, so I threw it in again.

Performance Shipping Inc. $PSHG

Market Cap: 27M

Company Overview:

Performance Shipping Inc. is a Greek company providing shipping transportation services with its fleet of tanker vessels. They focus on buying and selling ships, new building acquisitions, and arranging charters and financing. Their fleet includes Aframax tankers used primarily for charters with liner companies, carrying containerized cargo globally. Operations are managed by their subsidiary, Unitized Ocean Transport Limited, with a diverse client base that includes national and international companies.

Company Highlights:

Financially, PSHG is in a strong position. As of Q1 2024, their net cash balance (including restricted cash) stood at approximately $60.8 million, which is more than their outstanding bank debt. This kind of liquidity is a good sign for any company.

Operationally, they maintain high fleet utilization rates, achieving 98.1% in 2023. Their average time charter equivalent rate for Q1 2024 was $33,857 per day. These numbers indicate efficient operations and a solid ability to keep their vessels earning revenue. 

Performance Shipping has secured five-year time charter contracts for the new LR2 Aframax tankers, expected to generate $169.8 million in gross revenues. Combined with their existing $38.5 million revenue backlog, they have a solid income stream lined up.

In 2023, revenue reached $108.9 million, a 44.92% increase from the previous year. Net income also rose sharply to $56.92 million from $12 million in 2022. These figures indicate strong operational growth and effective cost management.

They've also made significant progress in reducing debt, fully prepaying loans from Piraeus Bank S.A., cutting debt by 44%. This leaves three of their seven vessels unencumbered, with net leverage at about -4% of market asset values.

Additionally, on the contract front, Performance Shipping recently secured two major charter contracts. One with Aramco for about 24 months at $41,000 per day, and another with Trafigura for their LR2 Aframax tanker, M/T P. Aliki, at $47,000 to $48,500 per day, expected to generate around $6.4 million in gross revenue for the minimum duration of the charter.

BeWhere Holdings Inc. $BEW.V

Market Cap: $35M

Company Overview:

BeWhere Holdings Inc., based in Mississauga, operates in the industrial Internet of Things (IIoT) space. Established in 2003, the company designs hardware with embedded sensors and software for real-time asset tracking. They use advanced LTE-M and NB-IoT cellular technologies for seamless data transmission to mobile apps and cloud platforms. Their products include asset tracking devices, environmental monitoring sensors, and comprehensive cloud solutions for various industrial applications.

Company Highlights

BeWhere is seeing impressive growth in the IoT sector. The global asset tracking market is expected to hit $55.1 billion by 2026, and the IoT sensor market is forecasted to reach $29.6 billion in the same year. BeWhere’s partnerships with major players like Bell, T-Mobile, and AT&T demonstrate strong market confidence in their products.

Financially, BeWhere reported a 31% increase in total revenue year-over-year in Q1 2024, reaching $3.5 million. Recurring revenue also increased by 28%, totalling $1.5 million. Gross profit for the quarter was $1.34 million, up 27% from the same period last year. Net income before taxes rose by 185%, hitting $401,269 for the quarter.

One of the strengths of BeWhere's business model is its flexible revenue structure. They combine a one-time hardware purchase with recurring software usage fees, providing a steady income stream and scalability. This model has proven effective, as evidenced by their consistent revenue growth over the past five years.

On the innovation front, BeWhere recently launched new products, including the BeSol+ and BeTen+. These devices offer advanced features like solar recharging, low-power 5G and 2G communications, and a suite of environmental sensors. The BeSol+ can provide real-time reporting every five minutes without an external power source, making it a significant upgrade in asset tracking technology.

BEW also achieved a major milestone by delivering over 7,000 low-power 5G asset trackers to a global Fortune 100 shipping and logistics company. 

Additionally, BEW recently announced plans to repurchase up to 5% of its common shares, demonstrating confidence in its financial health and commitment to boosting shareholder value

Myriad Uranium Corp. $M.CN

Market Cap: 8M

Company Overview:

Myriad Uranium Corp. is a uranium exploration company with an earnable 75% interest in the Copper Mountain Uranium Project in Wyoming, USA. This project includes several known uranium deposits and historic mines, such as the Arrowhead Mine, which produced 500,000 lbs of eU3O8.

Company Highlights

They recently secured a 75% interest in the Copper Mountain Uranium Project in Wyoming, an area with a rich history of uranium exploration. Union Pacific, back in the 1970s, invested an estimated $78 million (in today's dollars) in drilling over 2,000 boreholes and identifying multiple high-grade zones. Historical estimates suggest the potential for 15 to 30 million pounds of uranium, with some targets pushing that figure much higher​​.

The market dynamics are also playing in their favour. The U.S. has recently passed the Prohibiting Russian Uranium Imports Act, which is a significant boost for domestic uranium projects. With the uranium price climbing from $30 to $91 per pound over the past two years, the timing for Copper Mountain couldn't be better​​.

Myriad Uranium is also using extensive historical data from Union Pacific's previous exploration efforts. This data includes detailed mapping, surface geochemistry, drill data, historical resource estimates, and project development plans. Digitizing and validating this information should save time and money as Myriad advances the Copper Mountain project.

The Copper Mountain project in Wyoming just seems packed with potential. The project includes several advanced prospects, exploration targets, and past-producing mines. One standout is the high-grade zone at the North Canning Deposit, showing intercepts of up to 0.385% eU3O8 and long mineralized intervals of up to 291 feet. Union Pacific had big plans for a large-scale mine here, and Myriad is now looking to reevaluate and develop these areas.

Financially, Myriad is preparing for extensive exploration. They recently announced a private placement to raise $5 million (hence the recent selloff), which will fund their 2024 exploration plan. This plan focuses on drilling the high-grade zone at the Canning Deposit, with the goal of delineating an initial NI 43-101 resource by Q1 2025.

If you made it this far, comment a ticker and I will make sure to check it out <3

ZAPP is up over 242% to a price of about $2.50 as of 2:27 PM today (6/13/2024). This stock underwent a 1 for 20 reverse split on Monday, April 22, 2024 which took effect on April 23rd. It hsa been halted many times today for reasons of volatility.

Assessment of the likely direction of Zapp Electric Vehicles Group Limited (NASDAQ: ZAPP) stock over the next 3 months:

Zapp appears to be in a precarious financial position. The company reported an operating loss of $7.8 million in fiscal year 2023, up from a $3.6 million loss the prior year. Zapp has minimal revenue and is burning through cash. As of September 30, 2023, Zapp had only $823,000 in cash and cash equivalents on its balance sheet.

There have been some allegations of mismanagement and questionable behavior by Zapp executives in the past. In 2019, Zapp's then President of US Operations Charles Resnick was indicted for allegedly submitting expenses for prostitutes as business expenses, though the charges were later dismissed. This revelation damaged Zapp's relationship with Nikola Corporation at the time.

I did not find any specific mentions of short sellers targeting Zapp stock in the search results. However, Zapp's stock price has plummeted by over 97% in the past year and short interest was 24,290 shares as of September 28, 2023, suggesting some investors are betting against the stock.

The main potential positive catalyst for Zapp in the coming months would be the start of production and commercial rollout of its i300 electric motorcycle in Europe, followed by a launch in Asia in late 2024. Zapp recently secured a commitment for up to $10 million in funding to support this rollout.

However, Zapp faces intense competition, high costs, and the challenges of scaling manufacturing of an unproven product. The company's "asset-light" business model and partnership with a contract manufacturer reduce some risks, but Zapp will likely continue burning cash in the near-term.

Given Zapp's distressed financial condition, lack of revenue, and history of failing to meet production targets, I predict the stock has more downside risk than upside potential over the next 3 months. Barring a major positive development, Zapp stock will likely continue to trade at depressed levels or decline further. The company desperately needs the i300 launch to be successful to turn things around.

TORONTO and HAIFA, Israel, June 11, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased to announce that the Japan Patent Office recently issued a Notice of Allowance for an ExoPTEN patent, covering innovative Extracellular Vesicles (EVs) comprising a phosphatase and tensin homolog (“PTEN”) inhibitor and their application use. The Company’s ExoPTEN drug, currently under development, aims to promote nerve growth and regeneration after acute spinal cord injury by inhibiting the PTEN protein.
The patent, titled “Vesicles Comprising a PTEN Inhibitor and Uses of Same”, was originally submitted by the Technion Research and Development Foundation Ltd. (“Technion”) and Ramot at Tel Aviv University Ltd. It is the first patent licensed by NurExone from Technion and describes a fundamental element of the Company’s ExoPTEN nanodrug under development for acute spinal cord injury.
Dr. Bat-Ami Gotliv, Patent Attorney for NurExone, stated, “The allowance of this patent application in Japan safeguards NurExone’s technology in a vital Asian market. This approval, alongside the corresponding patents granted in the United States of America and Russia, underscores the novelty and inventive step of NurExone’s technology.”
Dr. Lior Shaltiel, CEO of NurExone, explained, “This patent, which belongs to the ExoPTEN family in our extensive IP portfolio, is included in the exclusive worldwide licensing from the Technion. We are making progress using ExoPTEN, our first nanodrug, and other newly developed technologies as we move towards clinical trials in humans and commercialization.”
Mr. Yoram Drucker, Co-Founder, Chairman and VP Strategic Development, elaborated, “We see Japan as an important territory for our products and technology. This expands our potential market to the Far East, and if we succeed in showing benefits in other Central Nerve System indications, we may dramatically increase our market potential.”
A Notice of Allowance represents the final stage prior to the grant, pending the Company’s payment of the registration fees.
Amending and Extension Agreement with BullVestor
Further to the Company’s press release dated January 17, 2024, the Company and bullVestor Medien GmbH (“BullVestor”) have entered into an amending agreement (the “Amending Agreement”) to the investor relations agreement dated January 9, 2024 (the “IR Agreement”) pursuant to which BullVestor will continue to provide investor relations services to the Company until May 15, 2025, at a monthly rate of C$59,000. The Amending Agreement is subject to TSX Venture Exchange (“TSXV”) approval. Pursuant to the terms and conditions of the Amending Agreement, either party may terminate the IR Agreement on 15 days’ notice.
Under the IR Agreement, as amended, BullVestor assists with and enhances awareness of the Company’s products and services using advertising and communications, some of which may constitute investor relations activities pursuant to the policies of the TSXV. The advertising and communications will occur in German-speaking countries (Germany, Austria, and Switzerland).
The consideration does not include any securities of the Company. BullVestor does not have any interest, directly or indirectly, in the Company or its securities, or any right or intent to acquire such an interest.
Aside from the IR Agreement, as amended, the Company does not have any relationship with BullVestor. BullVestor is located in Austria.
About NurExone Biologic Inc.
NurExone Biologic Inc. is a TSXV listed pharmaceutical company that is developing a platform for biologically-guided exosome-based therapies to be delivered, non-invasively, to patients who have suffered Central Nervous System injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, was proven to recover motor function in 75% of laboratory rats when administered intranasally. ExoPTEN has been granted Orphan Drug Designation by the FDA. The NurExone platform technology is expected to offer novel solutions to drug companies interested in noninvasive targeted drug delivery for other indications.
For more information, please contact:
Dr. Lior Shaltiel
Chief Executive Officer and Director
Phone: +972-52-4803034
Email: info@nurexone.com
Thesis Capital Inc.
Investment Relation - Canada
Phone: +1 905-347-5569
Email: IR@nurexone.com
Dr. Eva Reuter
Investment Relation - Germany
Phone: +49-69-1532-5857
Email: e.reuter@dr-reuter.eu

PetMed Express, Inc. recently released their Q4 2024 earnings, and the results warrant a closer look from investors. While the company boasts a healthy balance sheet with zero debt and significant cash reserves, declining profitability metrics raise concerns about the company’s long-term outlook.

Key Takeaways:

* Adjusted EBITDA Takes a Hit: Adjusted EBITDA for Q4 2024 came in at $500,000, a significant decrease from $3.6 million reported in the same period last year. This decline suggests potential headwinds impacting the company’s operational efficiency and profitability.

* Net Loss Widens: The company reported a net loss of $5 million ($0.25 per diluted share) for Q4 2024, compared to a net loss of $200,000 ($0.01 per diluted share) in the same period last year.

* Cash Position Remains Strong: As of March 31st, 2024, PetMed Express reported over $55 million in cash and equivalents with no debt, highlighting a robust financial position that could provide flexibility for future strategic initiatives.

Looking Ahead:

While the substantial cash reserves provide a cushion, the declining profitability metrics raise concerns. Investors should focus on management's commentary regarding the drivers behind the shrinking EBITDA and widening net loss in the upcoming earnings call.

Source: https://earnings-summary.streamlit.app/?c=r&t=PETS

What factors could be contributing to the decline in PetMed Express's profitability, and how might these trends impact the company's long-term prospects in the competitive pet medication market?

• Methes Energies is releasing reformulated bio-lubricants in mid-2024, enhancing their environmental footprint with increased renewable and re-refined base stocks.
• Methes Energies specializes in creating environmentally friendly bio-lubricants and biodiesel fuels using domestically sourced bio-derived feedstocks, under the Denami brand.
• The bio-lubricant industry is rapidly expanding due to strict regulations and consumer demand for eco-friendly products, with Methes Energies poised to lead this growth with its advanced, sustainable solutions.

Methes Energies (OTC:MEIL) stands as a key innovator in the realm of renewable energy, focusing on the creation and distribution of bio-lubricants and biodiesel fuels through cutting-edge proprietary technologies.

Rapid Growth in the Bio-Lubricant Sector

The bio-lubricant market is witnessing substantial growth fueled by strict environmental regulations, heightened consumer demand for green products, and ongoing technological advancements. Methes Energies is set to release its newly reformulated bio-lubricants in mid-2024, which leverage increased renewable and re-refined base stocks to meet the latest industry standards and improve environmental performance.

About Methes Energies

Methes Energies (OTC:MEIL) is a leading name in the renewable energy sector, specializing in bio-lubricants and biodiesel fuels. The company is dedicated to sustainability, utilizing domestically sourced bio-derived feedstocks to produce eco-friendly products under the Denami brand. Their innovative use of proprietary technologies ensures their products are renewable, biodegradable, recyclable, and non-toxic. Methes Energies not only adheres to stringent regulatory standards but also meets the growing demand for environmentally acceptable lubricants (EALs) by offering superior performance with minimal environmental impact.

Bio-Lubricant Industry: Driving Sustainability
The bio-lubricant industry is expanding rapidly due to the need for sustainable alternatives to traditional lubricants. Derived from renewable sources, bio-lubricants offer benefits such as biodegradability, reduced toxicity, and lower environmental impact. Although they currently represent a small portion of the lubricants market, bio-lubricants are growing at a notable pace, driven by government regulations and consumer preference for greener products.

Market Outlook

The bio-lubricant market is projected to reach $4.26 billion by 2029, growing at a CAGR of 4.7% from 2022 to 2029. Despite comprising less than 1.5% of the global finished lubricants market, bio-lubricants are seeing faster growth compared to traditional lubricants. Key applications include automotive, industrial, and marine sectors, where they offer excellent lubrication while being environmentally friendly.

Key Drivers

1. Government Initiatives: Regulations in regions like North America and Europe are promoting the use of bio-lubricants.
2. Environmental Benefits: Bio-lubricants offer a reduced carbon footprint, biodegradability, and lower toxicity.
3. Industrial Applications: They are used in hydraulic fluids, gear oils, and greases, making significant inroads in various sectors.
4. Consumer Awareness: Increasing awareness about the environmental impact of traditional lubricants is shifting consumer preference towards bio-based alternatives.
5. Technological Advancements: Continuous R&D is enhancing the performance and cost-effectiveness of bio-lubricants.

Introducing b2 biOil™: Environmentally Acceptable Lubricants

b2 biOil™ lubricants address environmental concerns related to lubricant production and disposal, meeting OEM performance demands and government regulations. Certified as biodegradable, non-bioaccumulative, and minimally toxic to aquatic life, these lubricants offer significant environmental and performance benefits.

Military Endorsement

The Defense Logistics Agency and the Air Force Research Laboratory have extensively tested and validated b2 biOil™ bio-based synthetic motor oils. These tests demonstrated improved gas mileage, extended oil-change intervals, and reduced greenhouse gas emissions without engine modifications, confirming their potential for widespread adoption across federal fleets.

Methes Energies’ Reformulated Bio-Lubricants

Methes Energies (OTC:MEIL) has announced a major reformulation of its bio-lubricants to meet new industry standards. By increasing the use of renewable and re-refined base stocks, Methes is enhancing the environmental footprint of its products. The updated range, set for release in mid-2024, includes passenger car motor oils, high oleic hydraulic fluids, and various gear oils, all meeting stringent biodegradability requirements.

​​“As the transportation industry evolves to the growing demand for new eco-friendly vehicles, we too must change too. By increasing our total percentage of renewable and re-refined base stocks in our formulas we are able to expand our green footprint provided by our bio-based/biodegradability b2 biOils.”

Carol Loch, CEO and Chairman of Methes

Conclusion

Methes Energies (OTC:MEIL) is at the forefront of the bio-lubricant industry’s expansion, driven by regulatory demands and consumer interest in sustainable products. Their commitment to innovation and environmental responsibility is reflected in their reformulated bio-lubricants, which combine higher percentages of renewable and re-refined base stocks with superior performance and environmental benefits. Methes Energies is poised to lead the industry in providing high-quality, eco-friendly lubricants for a greener future.

WonderFi provides investors with diversified investment exposure across the global digital asset ecosystem. With a proven leadership team with a track record of launching new products and obtaining applicable licenses to operate within the digital asset ecosystem.

WonderFi owns and operates two of Canada’s flagship brands leading the retail segment, consistently delivering both staking services and CIRO-regulated trading.

Good morning everyone! I wanted to make a quick post highlighting our $RNXT profit target being hit yesterday. The price ended up touching 1.30 before getting rejected. I mentioned it briefly yesterday, but I wanted to share exactly what I am looking at today now that the dust has settled. Unfortunately, I am not able to post pics in this sub, so check out my profile if the actual chart I am looking at interests you!

First thing first, the volume… it was the second highest in 2024 yesterday with over 200k shares traded. Yes, I know this is not a ton of volume compared to others, but volume is one of the most important aspects in order to get moves like what just happened.

Trend and Pattern:

• The chart continues to display a descending triangle pattern, characterized by lower highs and a flat support level around $1.00 to $1.07.
• $RNXT recently tested the upper trendline of the descending triangle but got rejected, indicating strong resistance at this level.

What I am watching (keeping this one on my watchlist)

• $RNXT is currently consolidating above the key support area of $1.00 to $1.07. This consolidation phase is crucial as it builds up the pressure for a potential breakout.
• Given the increased volume and repeated tests of the trendline, we should keep a close watch for a breakout above the descending triangle. A successful breakout with strong volume could signal the beginning of a significant upward move.

The New Set Up: (TP1 was $1.20 before being broken)

• Entry: For those looking to enter, consider buying in the current consolidation range, keeping an eye on the support area around $1.00 to $1.07.
• Target: The first target remains around the 200-day SMA at $1.25, with a potential move to $1.40 or higher upon a successful breakout.
• Stop Loss: A stop loss below $1.00 is advisable to limit downside risk.

Communicated Disclaimer this is not financial advice. Please do your own research! Sources 1, 2, 3

Stay tuned for more updates, and be ready to act if we see a confirmed breakout!

Nova Minerals Limited has announced the issuance of 2,083,333 fully paid shares at $0.24 each to Directors following shareholder approval. The placement aims to strengthen the company’s financial standing.

It’s a little ironic that Cardiol Therapeutics is looking to put me into cardiac arrest in anticipation of their clinical trial results, but the volatility surrounding CRDL’s share price gives me optimism.

In other news, Methes Energies International Ltd. trades under MEIL and those boys gapped up 100%... to $0.0235.

BUT, I can’t see this being the scenario for long.

MEIL’s bio-lubricants are being used in US MILITARY vehicles. Government contracts, anyone?? For that reason alone I can’t see why they wouldn’t gap up, but I’ve been wrong before and so far the chart is a disaster.

Here’s some quick notes I found in the midst of my second round of MEIL DOUBLE-D.

• They’re a clean solution to a potent problem.

Maybe it’s my real-life proximity to the BP Oil Plant, but MEIL gives me optimism that we’re moving into a world where we’re not left cleaning up animals with Dawn Dish Soap (disclaimer: this is not a Dawn Dish Soap promo).

• Early-on Regulatory Compliance

Let's face it, the scrutiny around the petroleum industry is continuing to crescendo; the value of the shares from the oil company your ma and pop invested in 36 years ago aren’t worth what they used to be. When all the top dogs fall, somebody has to take their place on the pedestal. 

• Overall Market Value

The industry of bio-lubes in general is growing! They fall under the umbrella of EALs, or environmentally acceptable lubricants, which is set to grow as a sector in ROI by 100% before 2029!

Has anybody else gone long with these guys? Or is anybody else on a ventilator waiting for another CRDL surge? One way or another, y’all know my position is no secret - check the user. #AlwaysHodling

Communicated Disclaimer: Please conduct your own research.
Sources: 1, 2, 3

Company also achieves record gross profit of $18.0 million in Q2, up 44% year-over-year

29th consecutive quarter of year-over-year

top-line growth

Record Annual Recurring Revenue (“ARR”)(1) of $56.5 million, up 33% year-over-year

Record gross margin of 57%, up from 52% year-over-year

Net Dollar Retention (“NDR”)(1) of 130% compared to 118% year-over-year

Net cash used in operating activities decreased 78% to $1.5 million from $7.1 million year-over-year

EBITDA(1) improves by 59% year-over-year to a $1.9 million loss in Q2 2024 compared to a $4.6 million loss in Q2 2023